NPI: 1023062452 · MONROE, NC 28110 · Pediatrics Physician · NPI assigned 05/20/2006
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 05/20/2006 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,704 | $912K |
| 2019 | 30,622 | $1.23M |
| 2020 | 28,132 | $1.20M |
| 2021 | 70,702 | $1.93M |
| 2022 | 83,020 | $2.06M |
| 2023 | 60,020 | $1.13M |
| 2024 | 42,956 | $114K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32,322 | 27,829 | $3.04M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20,357 | 17,230 | $1.32M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8,590 | 6,987 | $787K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12,769 | 11,014 | $639K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6,266 | 5,430 | $618K |
| 99199 | Unlisted special service, procedure or report | 135,146 | 132,550 | $481K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6,262 | 5,134 | $300K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2,111 | 1,822 | $205K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5,753 | 4,918 | $165K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,653 | 6,311 | $135K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 14,337 | 12,423 | $126K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 8,267 | 3,753 | $111K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11,362 | 9,872 | $102K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 858 | 760 | $90K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4,176 | 3,869 | $78K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2,192 | 2,049 | $68K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,055 | 874 | $67K |
| D0145 | Oral evaluation for a patient under three years of age | 1,357 | 1,254 | $48K |
| 96127 | 10,908 | 9,159 | $47K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,378 | 2,287 | $31K |
| 87807 | 2,086 | 1,751 | $28K | |
| D1206 | Topical application of fluoride varnish | 1,357 | 1,254 | $21K |
| 81003 | 7,159 | 6,268 | $11K | |
| 90461 | 7,904 | 6,714 | $10K | |
| 90474 | 455 | 420 | $9K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 160 | 141 | $6K |
| 99381 | 64 | 51 | $6K | |
| 90651 | 135 | 116 | $5K | |
| 90686 | 3,562 | 3,307 | $5K | |
| 96161 | 699 | 541 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 734 | 608 | $2K |
| 99215 | Prolong outpt/office vis | 16 | 12 | $2K |
| 92551 | 4,593 | 4,126 | $1K | |
| 99051 | 54 | 41 | $1K | |
| 90734 | 62 | 50 | $790.16 | |
| 99173 | 4,367 | 3,891 | $468.55 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 38 | 38 | $386.84 |
| 92567 | 30 | 28 | $381.92 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 18 | 14 | $319.03 |
| 99177 | 1,813 | 1,606 | $278.73 | |
| 90674 | 973 | 791 | $258.94 | |
| 90670 | 5,282 | 4,637 | $224.49 | |
| 88720 | 16 | 12 | $101.02 | |
| 90633 | 1,026 | 889 | $68.73 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 15 | 12 | $51.80 |
| 90680 | 2,586 | 2,269 | $0.00 | |
| 90698 | 2,394 | 2,130 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 38 | 38 | $0.00 |
| 90744 | 690 | 631 | $0.00 | |
| 90723 | 563 | 470 | $0.00 | |
| 90732 | 12 | 12 | $0.00 | |
| 90716 | 15 | 14 | $0.00 | |
| 90648 | 1,052 | 884 | $0.00 | |
| 92552 | 12 | 12 | $0.00 | |
| 90707 | 16 | 14 | $0.00 | |
| 90700 | 28 | 24 | $0.00 | |
| 90687 | 13 | 13 | $0.00 |